Vanda Pharmaceuticals
VNDA
#7202
Rank
NZ$0.81 B
Marketcap
NZ$13.81
Share price
4.59%
Change (1 day)
64.27%
Change (1 year)

Market capitalization of Vanda Pharmaceuticals (VNDA)

Market cap: NZ$0.81 Billion

As of March 2026 Vanda Pharmaceuticals has a market cap of NZ$0.81 Billion. This makes Vanda Pharmaceuticals the world's 7202th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vanda Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.81 B13.65%
2025NZ$0.71 B44.45%
2024NZ$0.49 B29.53%
2023NZ$0.38 B-41.72%
2022NZ$0.65 B-48.53%
2021NZ$1.27 B28.08%
2020NZ$0.99 B-23.42%
2019NZ$1.30 B-36.17%
2018NZ$2.04 B112.6%
2017NZ$0.96 B-4.98%
2016NZ$1.01 B73.75%
2015NZ$0.58 B-23.19%
2014NZ$0.75 B50.6%
2013NZ$0.50 B296.36%
2012NZ$0.12 B-25.93%
2011NZ$0.17 B-50.13%
2010NZ$0.34 B-19.48%
2009NZ$0.42 B1759.42%
2008NZ$22.96 M-90.41%
2007NZ$0.23 B-69.08%
2006NZ$0.77 B

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of Vanda Pharmaceuticals was reported to be:

NZ$0.78 Billion
by Nasdaq info icon info icon
NZ$0.78 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$995.78 B 121,865.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$537.77 B 65,766.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$254.95 B 31,127.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.513 T 185,218.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$500.93 B 61,255.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$213.81 B 26,088.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ$10.32 M-98.73%๐Ÿ‡บ๐Ÿ‡ธ USA